Macular Degeneration

Time course of morphologic effects on different retinal compartments after ranibizumab therapy in ag
PURPOSE: To analyze the effect of ranibizumab therapy on retinal and subretinal compartments in age-related macular degeneration and to compare the time course of compartment specific effects to visual function.

Vienna, Austria
Austria
Lutein and zeaxanthin for macular degeneration
PURPOSE: The effects of increasing lutein and zeaxanthin dosages in people with age-related macular degeneration (AMD) are discussed.

Ann Arbor, MI
USA
Cataract surgery and the development or progression of age-related macular degeneration: a systemati
Age-related macular degeneration and cataract are the most frequent eye disorders of elderly people worldwide.

Berlin, Germany
Germany
The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of ne
BACKGROUND: To examine if the significantly associated SNPs derived from the genome wide allelic association study on the AREDS cohort at the NEI (dbGAP) specifically confer risk for neovascular age-related macular degeneration (AMD).

Boston, MA
USA
Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration
BACKGROUND: The association between lutein/zeaxanthin intake and age-related macular degeneration (AMD) risk may differ by smoking status, vitamin C and E intakes, and body fatness.

Boston, MA 02115
USA
Preventing late-life depression in age-related macular degeneration
OBJECTIVE: To determine whether problem-solving treatment (PST) can prevent depressive disorders in patients with age-related macular degeneration (AMD).

Philadelphia, PA 19107
USA
Alcohol consumption and risk of aging macula disorder in a general population: the Rotterdam Study
OBJECTIVE: To investigate the possible relationship between overall or specific alcohol consumption and risk of aging macula disorder (AMD), a synonym for age-related macular degeneration, in a general population.

Rotterdam, The Netherlands
The Netherlands
Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degenera
OBJECTIVE: To systematically review the evidence on dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration (AMD).

Victoria, Australia
Australia
Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamc
PURPOSE: To evaluate combination treatment with reduced-fluence photodynamic therapy (PDT) and intravitreal triamcinolone acetonide (IVT) injection for choroidal neovascularization (CNV) in age-related macular degeneration (AMD).

Seattle, WA
USA
LOC387715, smoking and their prognostic impact on visual functional status in age-related macular de
PURPOSE: To prospectively evaluate the impact of homozygosity in the A69S-SNP of the LOC387715-gene, smoking history, and their interaction on visual functional status (v-FS) in age-related macular degeneration (AMD).

Muenster, Germany
Germany